INSM vs ZTS: stock comparison and AI forecast
Insmed Inc (INSM) and Zoetis Inc. (ZTS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
INSM Insmed Inc
- Market Cap
- $25.10B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
ZTS Zoetis Inc.
- Price
- $82.11 -6.0% · 6M
- Market Cap
- $33.93B
- P/E Ratio
- 14.0x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ZTS is 1.4 times larger than INSM by market capitalization ($33.93B against $25.10B).
- ZTS turns 26.1% of its revenue into net income, against -39.9% for INSM.
- ZTS carries 3.57 times debt per unit of equity, against 2.07 times for INSM.
- ZTS yields 2.61% in dividends; INSM pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | INSM | ZTS |
|---|---|---|
| Market Cap | $25.10B | $33.93B |
| P/E Ratio | – | 13.96x |
| P/B Ratio | 34.56x | 10.27x |
| Dividend Yield | – | 2.61% |
| EPS | $-2.01 | $5.88 |
| Book Value/Share | $3.31 | $7.99 |
| Revenue/Share | $6.93 | $23.01 |
| FCF/Share | $-2.86 | $5.51 |
Profitability & Margins
| Metric | INSM | ZTS |
|---|---|---|
| ROE | -83.4% | 75.3% |
| ROA | -27.2% | 16.5% |
| ROIC | -34.6% | – |
| Gross Margin | 84.4% | 71.3% |
| Operating Margin | -37.1% | – |
| Net Margin | -39.9% | 26.1% |
| EBT Margin | -39.4% | 32.8% |
| Tax Rate | -1.3% | 20.2% |
Financial Health
| Metric | INSM | ZTS |
|---|---|---|
| Current Ratio | 2.86x | 2.35x |
| Quick Ratio | 2.59x | 1.40x |
| D/E Ratio | 2.07x | 3.57x |
| Financial Leverage | 3.07x | 4.57x |
| Interest Coverage | -6.7x | – |
| Working Capital | $1.11B | $3.61B |
Cash Flow
| Metric | INSM | ZTS |
|---|---|---|
| Operating Cash Flow | -$596M | $2.77B |
| Free Cash Flow | -$628M | $2.28B |
| Capital Spending | -$32M | -$495M |
| OCF Growth YoY | – | -4.9% |
| FCF Growth YoY | – | 1.7% |
| FCF/Sales | -41.3% | 24.0% |
| CapEx/Sales | 2.1% | 5.2% |
Operational Efficiency
| Metric | INSM | ZTS |
|---|---|---|
| Asset Turnover | 0.68x | 0.63x |
| Receivables Turnover | 5.9x | 5.6x |
| Inventory Turnover | 1.4x | 1.1x |
| Fixed Assets Turnover | 14.0x | 2.5x |
| Days Sales Outstanding | 62 days | 65 days |
| Days Inventory | 252 days | 340 days |
| Payables Period | 130 days | 56 days |
| Cash Conversion Cycle | 185 days | 349 days |
Income Statement
| Metric | INSM | ZTS |
|---|---|---|
| Total Revenue | $1.52B | $9.51B |
| Operating Income | -$564M | – |
| Net Income | -$606M | $2.49B |
| R&D Expense | $944M | $726M |
| SG&A Expense | $960M | $2.38B |
| Cost of Goods Sold | $237M | $2.72B |
Dividend & Shareholder Information
| Metric | INSM | ZTS |
|---|---|---|
| Dividends Per Share | – | $2.14 |
| Payout Ratio | – | 36.4% |
| Shares Outstanding | 219M | 413M |
| Net Income Growth | – | -6.2% |
| EPS Growth | – | -1.0% |
INSM vs ZTS: stock comparison and AI forecast
Which is bigger, INSM or ZTS?
ZTS is 1.4 times larger than INSM by market capitalization ($33.93B against $25.10B).
Which one does Intratio's AI model rank higher, INSM or ZTS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.